CEO: Laura Cerqueira
Biomode's kits detect specific micro-organisms within hours, providing an analysis regarding the organism's resistance to antibiotics. The technology prevents prolonged and erroneous treatments, false negatives and side effects detrimental to patients.
CEO: João Fonseca
Company of development and production of innovation technologies for the market of patient-based diagnostic tests (Point-of-Care). The spinit® solution is the first and only one to allow one blood drop analysis, presenting results of parameters of different diagnostic specialties (hematology, immunoassay and clinical chemistry) in less than 5 minutes using always the same equipment of reading.
CEO: Bruno Sommer Ferreira
Provides advanced services for the development, optimisation, intensification and scale-up of industrial biotechnology processes.
CEO: Rui Brito
BSIM2 develops technology for the development of medication used to fight neurodegenerative amyloid diseases.